Edwards JC, Cambridge G: Prospects for B-cell-targeted therapy in autoimmune disease. Rheumatology (Oxford). 2005, 44: 151-156. 10.1093/rheumatology/keh446.
CAS
Google Scholar
Nakken B, Munthe LA, Konttinen YT, Sandberg AK, Szekanecz Z, Alex P, Szodoray P: B-cells and their targeting in rheumatoid arthritis - current concepts and future perspectives. Autoimmun Rev. 2011, 11: 28-34. 10.1016/j.autrev.2011.06.010.
CAS
PubMed
Google Scholar
Yildirim-Toruner C, Diamond B: Current and novel therapeutics in the treatment of systemic lupus erythematosus. J Allergy Clin Immunol. 2011, 127: 303-312. 10.1016/j.jaci.2010.12.1087. quiz 313-4
PubMed Central
CAS
PubMed
Google Scholar
Kuraoka M, Kelsoe G: A novel role for activation-induced cytidine deaminase: central B-cell tolerance. Cell Cycle. 2011, 10: 3423-3424. 10.4161/cc.10.20.17693.
CAS
PubMed
Google Scholar
Meffre E: The establishment of early B cell tolerance in humans: lessons from primary immunodeficiency diseases. Ann N Y Acad Sci. 2011, 1246: 1-10. 10.1111/j.1749-6632.2011.06347.x.
PubMed Central
CAS
PubMed
Google Scholar
Pillai S, Mattoo H, Cariappa A: B cells and autoimmunity. Curr Opin Immunol. 2011, 23: 721-731. 10.1016/j.coi.2011.10.007.
PubMed Central
CAS
PubMed
Google Scholar
Stavnezer J: Complex regulation and function of activation-induced cytidine deaminase. Trends Immunol. 2011, 32: 194-201. 10.1016/j.it.2011.03.003.
PubMed Central
CAS
PubMed
Google Scholar
Suryani S, Fulcher DA, Santner-Nanan B, Nanan R, Wong M, Shaw PJ, Gibson J, Williams A, Tangye SG: Differential expression of CD21 identifies developmentally and functionally distinct subsets of human transitional B cells. Blood. 2010, 115: 519-529. 10.1182/blood-2009-07-234799.
CAS
PubMed
Google Scholar
Meffre E, Wardemann H: B-cell tolerance checkpoints in health and autoimmunity. Curr Opin Immunol. 2008, 20: 632-638. 10.1016/j.coi.2008.09.001.
CAS
PubMed
Google Scholar
Isnardi I, Ng YS, Menard L, Meyers G, Saadoun D, Srdanovic I, Samuels J, Berman J, Buckner JH, Cunningham-Rundles C, Meffre E: Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones. Blood. 2010, 115: 5026-5036. 10.1182/blood-2009-09-243071.
PubMed Central
CAS
PubMed
Google Scholar
Yurasov S, Wardemann H, Hammersen J, Tsuiji M, Meffre E, Pascual V, Nussenzweig MC: Defective B cell tolerance checkpoints in systemic lupus erythematosus. J Exp Med. 2005, 201: 703-711. 10.1084/jem.20042251.
PubMed Central
CAS
PubMed
Google Scholar
Vossenkamper A, Lutalo PM, Spencer J: Translational mini-review series on B cell subsets in disease. Transitional B cells in systemic lupus erythematosus and Sjogren's syndrome: clinical implications and effects of B cell-targeted therapies. Clin Exp Immunol. 2012, 167: 7-14. 10.1111/j.1365-2249.2011.04460.x.
PubMed Central
CAS
PubMed
Google Scholar
Menard L, Saadoun D, Isnardi I, Ng YS, Meyers G, Massad C, Price C, Abraham C, Motaghedi R, Buckner JH, Gregersen PK, Meffre E: The PTPN22 allele encoding an R620W variant interferes with the removal of developing autoreactive B cells in humans. J Clin Invest. 2011, 121: 3635-3644. 10.1172/JCI45790.
PubMed Central
CAS
PubMed
Google Scholar
Rhee I, Veillette A: Protein tyrosine phosphatases in lymphocyte activation and autoimmunity. Nat Immunol. 2012, 13: 439-447. 10.1038/ni.2246.
CAS
PubMed
Google Scholar
Arechiga AF, Habib T, He Y, Zhang X, Zhang ZY, Funk A, Buckner JH: Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling. J Immunol. 2009, 182: 3343-3347. 10.4049/jimmunol.0713370.
PubMed Central
CAS
PubMed
Google Scholar
Zhang J, Zahir N, Jiang Q, Miliotis H, Heyraud S, Meng X, Dong B, Xie G, Qiu F, Hao Z, McCulloch CA, Keystone EC, Peterson AC, Siminovitch KA: The autoimmune disease-associated PTPN22 variant promotes calpain-mediated Lyp/Pep degradation associated with lymphocyte and dendritic cell hyperresponsiveness. Nat Genet. 2011, 43: 902-907. 10.1038/ng.904.
CAS
PubMed
Google Scholar
Horwood NJ, Urbaniak AM, Danks L: Tec family kinases in inflammation and disease. Int Rev Immunol. 2012, 31: 87-103. 10.3109/08830185.2012.670334.
CAS
PubMed
Google Scholar
Fukui R, Saitoh S, Kanno A, Onji M, Shibata T, Ito A, Onji M, Matsumoto M, Akira S, Yoshida N, Miyake K: Unc93B1 restricts systemic lethal inflammation by orchestrating Toll-like receptor 7 and 9 trafficking. Immunity. 2011, 35: 69-81. 10.1016/j.immuni.2011.05.010.
CAS
PubMed
Google Scholar
Itoh H, Tatematsu M, Watanabe A, Iwano K, Funami K, Seya T, Matsumoto M: UNC93B1 physically associates with human TLR8 and regulates TLR8-mediated signaling. PLoS One. 2011, 6: e28500-10.1371/journal.pone.0028500.
PubMed Central
CAS
PubMed
Google Scholar
Kil LP, de Bruijn MJ, van Nimwegen M, Corneth OB, van Hamburg JP, Dingjan GM, Thaiss F, Rimmelzwaan GF, Elewaut D, Delsing D, van Loo PF, Hendriks RW: Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice. Blood. 2011, 119: 3744-3756.
Google Scholar
Mackay F, Silveira PA, Brink R: B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling. Curr Opin Immunol. 2007, 19: 327-336. 10.1016/j.coi.2007.04.008.
CAS
PubMed
Google Scholar
Liu Z, Davidson A: BAFF and selection of autoreactive B cells. Trends Immunol. 2011, 32: 388-394. 10.1016/j.it.2011.06.004.
PubMed Central
CAS
PubMed
Google Scholar
Groom JR, Fletcher CA, Walters SN, Grey ST, Watt SV, Sweet MJ, Smyth MJ, Mackay CR, Mackay F: BAFF and MyD88 signals promote a lupuslike disease independent of T cells. J Exp Med. 2007, 204: 1959-1971. 10.1084/jem.20062567.
PubMed Central
CAS
PubMed
Google Scholar
Bombardieri M, Kam NW, Brentano F, Choi K, Filer A, Kyburz D, McInnes IB, Gay S, Buckley C, Pitzalis C: A BAFF/APRIL-dependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce AID expression and Ig class-switching in B cells. Ann Rheum Dis. 2011, 70: 1857-1865. 10.1136/ard.2011.150219.
CAS
PubMed
Google Scholar
Acosta-Rodriguez EV, Craxton A, Hendricks DW, Merino MC, Montes CL, Clark EA, Gruppi A: BAFF and LPS cooperate to induce B cells to become susceptible to CD95/Fas-mediated cell death. Eur J Immunol. 2007, 37: 990-1000. 10.1002/eji.200636698.
CAS
PubMed
Google Scholar
Chappell CP, Jacob J: Germinal-center-derived B-cell memory. Adv Exp Med Biol. 2007, 590: 139-148. 10.1007/978-0-387-34814-8_10.
PubMed
Google Scholar
Goodnow CC, Vinuesa CG, Randall KL, Mackay F, Brink R: Control systems and decision making for antibody production. Nat Immunol. 2010, 11: 681-688.
CAS
PubMed
Google Scholar
Tiller T, Kofer J, Kreschel C, Busse CE, Riebel S, Wickert S, Oden F, Mertes MM, Ehlers M, Wardemann H: Development of self-reactive germinal center B cells and plasma cells in autoimmune FcγRIIB-deficient mice. J Exp Med. 2010, 207: 2767-2778. 10.1084/jem.20100171.
PubMed Central
CAS
PubMed
Google Scholar
Guo W, Smith D, Aviszus K, Detanico T, Heiser RA, Wysocki LJ: Somatic hypermutation as a generator of antinuclear antibodies in a murine model of systemic autoimmunity. J Exp Med. 2010, 207: 2225-2237. 10.1084/jem.20092712.
PubMed Central
CAS
PubMed
Google Scholar
Mietzner B, Tsuiji M, Scheid J, Velinzon K, Tiller T, Abraham K, Gonzalez JB, Pascual V, Stichweh D, Wardemann H, Nussenzweig MC: Autoreactive IgG memory antibodies in patients with systemic lupus erythematosus arise from nonreactive and polyreactive precursors. Proc Natl Acad Sci USA. 2008, 105: 9727-9732. 10.1073/pnas.0803644105.
PubMed Central
CAS
PubMed
Google Scholar
Tiller T, Tsuiji M, Yurasov S, Velinzon K, Nussenzweig MC, Wardemann H: Autoreactivity in human IgG+ memory B cells. Immunity. 2007, 26: 205-213. 10.1016/j.immuni.2007.01.009.
PubMed Central
CAS
PubMed
Google Scholar
Linterman MA, Rigby RJ, Wong RK, Yu D, Brink R, Cannons JL, Schwartzberg PL, Cook MC, Walters GD, Vinuesa CG: Follicular helper T cells are required for systemic autoimmunity. J Exp Med. 2009, 206: 561-576. 10.1084/jem.20081886.
PubMed Central
CAS
PubMed
Google Scholar
Vuyyuru R, Mohan C, Manser T, Rahman ZS: The lupus susceptibility locus Sle1 breaches peripheral B cell tolerance at the antibody-forming cell and germinal center checkpoints. J Immunol. 2009, 183: 5716-5727. 10.4049/jimmunol.0804215.
PubMed Central
CAS
PubMed
Google Scholar
Scheid JF, Mouquet H, Kofer J, Yurasov S, Nussenzweig MC, Wardemann H: Differential regulation of self-reactivity discriminates between IgG+ human circulating memory B cells and bone marrow plasma cells. Proc Natl Acad Sci USA. 2011, 108: 18044-18048. 10.1073/pnas.1113395108.
PubMed Central
CAS
PubMed
Google Scholar
Chappell CP, Jacob J: Identification of memory B cells using a novel transgenic mouse model. J Immunol. 2006, 176: 4706-4715.
CAS
PubMed
Google Scholar
Blink EJ, Light A, Kallies A, Nutt SL, Hodgkin PD, Tarlinton DM: Early appearance of germinal center-derived memory B cells and plasma cells in blood after primary immunization. J Exp Med. 2005, 201: 545-554. 10.1084/jem.20042060.
PubMed Central
CAS
PubMed
Google Scholar
Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB: Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003, 349: 1526-1533. 10.1056/NEJMoa021933.
CAS
PubMed
Google Scholar
Townsend MJ, Monroe JG, Chan AC: B-cell targeted therapies in human autoimmune diseases: an updated perspective. Immunol Rev. 2010, 237: 264-283. 10.1111/j.1600-065X.2010.00945.x.
CAS
PubMed
Google Scholar
Mao C, Jiang L, Melo-Jorge M, Puthenveetil M, Zhang X, Carroll MC, Imanishi-Kari T: T cell-independent somatic hypermutation in murine B cells with an immature phenotype. Immunity. 2004, 20: 133-144. 10.1016/S1074-7613(04)00019-6.
CAS
PubMed
Google Scholar
Han JH, Akira S, Calame K, Beutler B, Selsing E, Imanishi-Kari T: Class switch recombination and somatic hypermutation in early mouse B cells are mediated by B cell and Toll-like receptors. Immunity. 2007, 27: 64-75. 10.1016/j.immuni.2007.05.018.
PubMed Central
CAS
PubMed
Google Scholar
Ueda Y, Liao D, Yang K, Patel A, Kelsoe G: T-independent activation-induced cytidine deaminase expression, class-switch recombination, and antibody production by immature/transitional 1 B cells. J Immunol. 2007, 178: 3593-3601.
PubMed Central
CAS
PubMed
Google Scholar
Aranburu A, Ceccarelli S, Giorda E, Lasorella R, Ballatore G, Carsetti R: TLR ligation triggers somatic hypermutation in transitional B cells inducing the generation of IgM memory B cells. J Immunol. 2010, 185: 7293-7301. 10.4049/jimmunol.1002722.
CAS
PubMed
Google Scholar
Guo P, Hirano M, Herrin BR, Li J, Yu C, Sadlonova A, Cooper MD: Dual nature of the adaptive immune system in lampreys. Nature. 2009, 459: 796-801. 10.1038/nature08068.
PubMed Central
CAS
PubMed
Google Scholar
Meyers G, Ng YS, Bannock JM, Lavoie A, Walter JE, Notarangelo LD, Kilic SS, Aksu G, Debre M, Rieux-Laucat F, Conley ME, Cunningham-Rundles C, Durandy A, Meffre E: Activation-induced cytidine deaminase (AID) is required for B-cell tolerance in humans. Proc Natl Acad Sci USA. 2011, 108: 11554-11559. 10.1073/pnas.1102600108.
PubMed Central
CAS
PubMed
Google Scholar
Kuraoka M, Holl TM, Liao D, Womble M, Cain DW, Reynolds AE, Kelsoe G: Activation-induced cytidine deaminase mediates central tolerance in B cells. Proc Natl Acad Sci USA. 2011, 108: 11560-11565. 10.1073/pnas.1102571108.
PubMed Central
PubMed
Google Scholar
William J, Euler C, Christensen S, Shlomchik MJ: Evolution of autoantibody responses via somatic hypermutation outside of germinal centers. Science. 2002, 297: 2066-2070. 10.1126/science.1073924.
CAS
PubMed
Google Scholar
Sweet RA, Ols ML, Cullen JL, Milam AV, Yagita H, Shlomchik MJ: Facultative role for T cells in extrafollicular Toll-like receptor-dependent autoreactive B-cell responses in vivo. Proc Natl Acad Sci USA. 2011, 108: 7932-7937. 10.1073/pnas.1018571108.
PubMed Central
CAS
PubMed
Google Scholar
He B, Qiao X, Cerutti A: CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10. J Immunol. 2004, 173: 4479-4491.
CAS
PubMed
Google Scholar
Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, Casali P, Cerutti A: DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol. 2002, 3: 822-829.
PubMed Central
CAS
PubMed
Google Scholar
He B, Santamaria R, Xu W, Cols M, Chen K, Puga I, Shan M, Xiong H, Bussel JB, Chiu A, Puel A, Reichenbach J, Marodi L, Doffinger R, Vasconcelos J, Issekutz A, Krause J, Davies G, Li X, Grimbacher B, Plebani A, Meffre E, Picard C, Cunningham-Rundles C, Casanova JL, Cerutti A: The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat Immunol. 2010, 11: 836-845. 10.1038/ni.1914.
PubMed Central
CAS
PubMed
Google Scholar
Ngo VN, Korner H, Gunn MD, Schmidt KN, Riminton DS, Cooper MD, Browning JL, Sedgwick JD, Cyster JG: Lymphotoxin alpha/beta and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J Exp Med. 1999, 189: 403-412. 10.1084/jem.189.2.403.
PubMed Central
CAS
PubMed
Google Scholar
Hamaguchi Y, Uchida J, Cain DW, Venturi GM, Poe JC, Haas KM, Tedder TF: The peritoneal cavity provides a protective niche for B1 and conventional B lymphocytes during anti-CD20 immunotherapy in mice. J Immunol. 2005, 174: 4389-4399.
CAS
PubMed
Google Scholar
Astorri E, Bombardieri M, Gabba S, Peakman M, Pozzilli P, Pitzalis C: Evolution of ectopic lymphoid neogenesis and in situ autoantibody production in autoimmune nonobese diabetic mice: cellular and molecular characterization of tertiary lymphoid structures in pancreatic islets. J Immunol. 2010, 185: 3359-3368. 10.4049/jimmunol.1001836.
CAS
PubMed
Google Scholar
Humby F, Bombardieri M, Manzo A, Kelly S, Blades MC, Kirkham B, Spencer J, Pitzalis C: Ectopic lymphoid structures support ongoing production of class-switched autoantibodies in rheumatoid synovium. PLoS Med. 2009, 6: e1-
PubMed Central
PubMed
Google Scholar
Victora GD, Nussenzweig MC: Germinal centers. Annu Rev Immunol. 2012, 30: 429-457. 10.1146/annurev-immunol-020711-075032.
CAS
PubMed
Google Scholar
Dudziak D, Kamphorst AO, Heidkamp GF, Buchholz VR, Trumpfheller C, Yamazaki S, Cheong C, Liu K, Lee HW, Park CG, Steinman RM, Nussenzweig MC: Differential antigen processing by dendritic cell subsets in vivo. Science. 2007, 315: 107-111. 10.1126/science.1136080.
CAS
PubMed
Google Scholar
Sancho D, Joffre OP, Keller AM, Rogers NC, Martinez D, Hernanz-Falcon P, Rosewell I, Reis e Sousa C: Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature. 2009, 458: 899-903. 10.1038/nature07750.
PubMed Central
CAS
PubMed
Google Scholar
Gaipl US, Voll RE, Sheriff A, Franz S, Kalden JR, Herrmann M: Impaired clearance of dying cells in systemic lupus erythematosus. Autoimmun Rev. 2005, 4: 189-194. 10.1016/j.autrev.2004.10.007.
CAS
PubMed
Google Scholar
Jego G, Pascual V, Palucka AK, Banchereau J: Dendritic cells control B cell growth and differentiation. Curr Dir Autoimmun. 2005, 8: 124-139.
CAS
PubMed
Google Scholar
Tangye SG: Plasmacytoid DCs induce gutsy plasma cells. Immunity. 2011, 34: 144-146. 10.1016/j.immuni.2011.02.009.
CAS
PubMed
Google Scholar
Bergtold A, Desai DD, Gavhane A, Clynes R: Cell surface recycling of internalized antigen permits dendritic cell priming of B cells. Immunity. 2005, 23: 503-514. 10.1016/j.immuni.2005.09.013.
CAS
PubMed
Google Scholar
Qi H, Egen JG, Huang AY, Germain RN: Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells. Science. 2006, 312: 1672-1676. 10.1126/science.1125703.
CAS
PubMed
Google Scholar
Teichmann LL, Ols ML, Kashgarian M, Reizis B, Kaplan DH, Shlomchik MJ: Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage. Immunity. 2010, 33: 967-978. 10.1016/j.immuni.2010.11.025.
PubMed Central
CAS
PubMed
Google Scholar
Chappell CP, Draves KE, Giltiay NV, Clark EA: Extrafollicular B cell activation by marginal zone dendritic cells drives T cell-dependent antibody responses. J Exp Med. 2012,
Google Scholar
Green NM, Marshak-Rothstein A: Toll-like receptor driven B cell activation in the induction of systemic autoimmunity. Semin Immunol. 2011, 23: 106-112. 10.1016/j.smim.2011.01.016.
PubMed Central
CAS
PubMed
Google Scholar
Lau CM, Broughton C, Tabor AS, Akira S, Flavell RA, Mamula MJ, Christensen SR, Shlomchik MJ, Viglianti GA, Rifkin IR, Marshak-Rothstein A: RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med. 2005, 202: 1171-1177. 10.1084/jem.20050630.
PubMed Central
CAS
PubMed
Google Scholar
Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A: Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature. 2002, 416: 603-607. 10.1038/416603a.
CAS
PubMed
Google Scholar
Viglianti GA, Lau CM, Hanley TM, Miko BA, Shlomchik MJ, Marshak-Rothstein A: Activation of autoreactive B cells by CpG dsDNA. Immunity. 2003, 19: 837-847. 10.1016/S1074-7613(03)00323-6.
CAS
PubMed
Google Scholar
Bijl M, Reefman E, Horst G, Limburg PC, Kallenberg CG: Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement. Ann Rheum Dis. 2006, 65: 57-63. 10.1136/ard.2005.035733.
PubMed Central
CAS
PubMed
Google Scholar
Ren Y, Tang J, Mok MY, Chan AW, Wu A, Lau CS: Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum. 2003, 48: 2888-2897. 10.1002/art.11237.
PubMed
Google Scholar
Uccellini MB, Busconi L, Green NM, Busto P, Christensen SR, Shlomchik MJ, Marshak-Rothstein A, Viglianti GA: Autoreactive B cells discriminate CpG-rich and CpG-poor DNA and this response is modulated by IFN-alpha. J Immunol. 2008, 181: 5875-5884.
PubMed Central
CAS
PubMed
Google Scholar
Ballestar E: Epigenetic alterations in autoimmune rheumatic diseases. Nat Rev Rheumatol. 2011, 7: 263-271. 10.1038/nrrheum.2011.16.
CAS
PubMed
Google Scholar
Diebold SS: Recognition of viral single-stranded RNA by Toll-like receptors. Adv Drug Deliv Rev. 2008, 60: 813-823. 10.1016/j.addr.2007.11.004.
CAS
PubMed
Google Scholar
Cyster JG: B cell follicles and antigen encounters of the third kind. Nat Immunol. 2010, 11: 989-996. 10.1038/ni.1946.
CAS
PubMed
Google Scholar
Hakkim A, Furnrohr BG, Amann K, Laube B, Abed UA, Brinkmann V, Herrmann M, Voll RE, Zychlinsky A: Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci USA. 2010, 107: 9813-9818. 10.1073/pnas.0909927107.
PubMed Central
CAS
PubMed
Google Scholar
Puga I, Cols M, Barra CM, He B, Cassis L, Gentile M, Comerma L, Chorny A, Shan M, Xu W, G Knowles DM, Tam W, Chiu A, Bussel JB, Serrano S, Lorente JA, Bellosillo B, Lloreta J, Juanpere N, Alameda F, Baro T, de Heredia CD, Toran N, Catala A, Torrebadell M, Fortuny C, Cusi V, Carreras C, Diaz GA: B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat Immunol. 2012, 13: 170-180.
CAS
Google Scholar
Giltiay NV: TLR7 overexpression drives autoantigen-mediated expansion of transitional and follicular B cells independently of type I IFN signals [abstract]. Arthritis Rheum. 2011, 63 (Suppl 10): 2548-
Google Scholar
Latz E, Schoenemeyer A, Visintin A, Fitzgerald KA, Monks BG, Knetter CF, Lien E, Nilsen NJ, Espevik T, Golenbock DT: TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol. 2004, 5: 190-198.
CAS
PubMed
Google Scholar
Chaturvedi A, Dorward D, Pierce SK: The B cell receptor governs the subcellular location of Toll-like receptor 9 leading to hyperresponses to DNA-containing antigens. Immunity. 2008, 28: 799-809. 10.1016/j.immuni.2008.03.019.
PubMed Central
CAS
PubMed
Google Scholar
Saitoh S, Miyake K: Regulatory molecules required for nucleotide-sensing Toll-like receptors. Immunol Rev. 2009, 227: 32-43. 10.1111/j.1600-065X.2008.00729.x.
CAS
PubMed
Google Scholar
Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ: Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity. 2006, 25: 417-428. 10.1016/j.immuni.2006.07.013.
CAS
PubMed
Google Scholar
Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB, Bolland S: Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science. 2006, 312: 1669-1672. 10.1126/science.1124978.
CAS
PubMed
Google Scholar
Deane JA, Pisitkun P, Barrett RS, Feigenbaum L, Town T, Ward JM, Flavell RA, Bolland S: Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity. 2007, 27: 801-810. 10.1016/j.immuni.2007.09.009.
PubMed Central
CAS
PubMed
Google Scholar
Christensen SR, Kashgarian M, Alexopoulou L, Flavell RA, Akira S, Shlomchik MJ: Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus. J Exp Med. 2005, 202: 321-331. 10.1084/jem.20050338.
PubMed Central
CAS
PubMed
Google Scholar
Santiago-Raber ML, Dunand-Sauthier I, Wu T, Li QZ, Uematsu S, Akira S, Reith W, Mohan C, Kotzin BL, Izui S: Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice. J Autoimmun. 2010, 34: 339-348. 10.1016/j.jaut.2009.11.001.
CAS
PubMed
Google Scholar
Demaria O, Pagni PP, Traub S, de Gassart A, Branzk N, Murphy AJ, Valenzuela DM, Yancopoulos GD, Flavell RA, Alexopoulou L: TLR8 deficiency leads to autoimmunity in mice. J Clin Invest. 2010, 120: 3651-3662.
PubMed Central
CAS
PubMed
Google Scholar
Kawasaki A, Furukawa H, Kondo Y, Ito S, Hayashi T, Kusaoi M, Matsumoto I, Tohma S, Takasaki Y, Hashimoto H, Sumida T, Tsuchiya N: TLR7 single-nucleotide polymorphisms in the 3' untranslated region and intron 2 independently contribute to systemic lupus erythematosus in Japanese women: a case-control association study. Arthritis Res Ther. 2011, 13: R41-10.1186/ar3277.
PubMed Central
CAS
PubMed
Google Scholar
Shen N, Fu Q, Deng Y, Qian X, Zhao J, Kaufman KM, Wu YL, Yu CY, Tang Y, Chen JY, Yang W, Wong M, Kawasaki A, Tsuchiya N, Sumida T, Kawaguchi Y, Howe HS, Mok MY, Bang SY, Liu FL, Chang DM, Takasaki Y, Hashimoto H, Harley JB, Guthridge JM, Grossman JM, Cantor RM, Song YW, Bae SC, Chen S: Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc Natl Acad Sci USA. 2010, 107: 15838-15843. 10.1073/pnas.1001337107.
PubMed Central
CAS
PubMed
Google Scholar
Tao K, Fujii M, Tsukumo S, Maekawa Y, Kishihara K, Kimoto Y, Horiuchi T, Hisaeda H, Akira S, Kagami S, Yasutomo K: Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population. Ann Rheum Dis. 2007, 66: 905-909. 10.1136/ard.2006.065961.
PubMed Central
CAS
PubMed
Google Scholar
Friedman RM, Preble O, Black R, Harrell S: Interferon production in patients with systemic lupus erythematosus. Arthritis Rheum. 1982, 25: 802-803. 10.1002/art.1780250717.
CAS
PubMed
Google Scholar
Hooks JJ, Jordan GW, Cupps T, Moutsopoulos HM, Fauci AS, Notkins AL: Multiple interferons in the circulation of patients with systemic lupus erythematosus and vasculitis. Arthritis Rheum. 1982, 25: 396-400. 10.1002/art.1780250406.
CAS
PubMed
Google Scholar
Preble OT, Black RJ, Friedman RM, Klippel JH, Vilcek J: Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon. Science. 1982, 216: 429-431. 10.1126/science.6176024.
CAS
PubMed
Google Scholar
Elkon KB, Stone VV: Type I interferon and systemic lupus erythematosus. J Interferon Cytokine Res. 2011, 31: 803-812. 10.1089/jir.2011.0045.
PubMed Central
CAS
PubMed
Google Scholar
Ronnblom L: The type I interferon system in the etiopathogenesis of autoimmune diseases. Ups J Med Sci. 2011, 116: 227-237. 10.3109/03009734.2011.624649.
PubMed Central
PubMed
Google Scholar
Pascual V, Farkas L, Banchereau J: Systemic lupus erythematosus: all roads lead to type I interferons. Curr Opin Immunol. 2006, 18: 676-682. 10.1016/j.coi.2006.09.014.
CAS
PubMed
Google Scholar
Swanson CL, Wilson TJ, Strauch P, Colonna M, Pelanda R, Torres RM: Type I IFN enhances follicular B cell contribution to the T cell-independent antibody response. J Exp Med. 2010, 207: 1485-1500. 10.1084/jem.20092695.
PubMed Central
CAS
PubMed
Google Scholar
Green NM, Laws A, Kiefer K, Busconi L, Kim YM, Brinkmann MM, Trail EH, Yasuda K, Christensen SR, Shlomchik MJ, Vogel S, Connor JH, Ploegh H, Eilat D, Rifkin IR, van Seventer JM, Marshak-Rothstein A: Murine B cell response to TLR7 ligands depends on an IFN-beta feedback loop. J Immunol. 2009, 183: 1569-1576. 10.4049/jimmunol.0803899.
PubMed Central
CAS
PubMed
Google Scholar
Thibault DL, Chu AD, Graham KL, Balboni I, Lee LY, Kohlmoos C, Landrigan A, Higgins JP, Tibshirani R, Utz PJ: IRF9 and STAT1 are required for IgG autoantibody production and B cell expression of TLR7 in mice. J Clin Invest. 2008, 118: 1417-1426. 10.1172/JCI30065.
PubMed Central
CAS
PubMed
Google Scholar
Bekeredjian-Ding IB, Wagner M, Hornung V, Giese T, Schnurr M, Endres S, Hartmann G: Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN. J Immunol. 2005, 174: 4043-4050.
PubMed
Google Scholar
Rosado MM, Diamanti AP, Capolunghi F, Carsetti R: B cell modulation strategies in autoimmunity: the SLE example. Curr Pharm Des. 2011, 17: 3155-3165. 10.2174/138161211798157612.
CAS
PubMed
Google Scholar
Marian V, Anolik JH: Treatment targets in systemic lupus erythematosus: biology and clinical perspective. Arthritis Res Therapy. 2012, 14 (Suppl 4): S3.-
Google Scholar
Woyach JA, Johnson AJ, Byrd JC: The B-cell receptor signaling pathway as a therapeutic target in CLL. Blood. 2012, 120: 1175-1184. 10.1182/blood-2012-02-362624.
PubMed Central
CAS
PubMed
Google Scholar
Scott DL: Role of spleen tyrosine kinase inhibitors in the management of rheumatoid arthritis. Drugs. 2011, 71: 1121-1132. 10.2165/11591480-000000000-00000.
CAS
PubMed
Google Scholar
Bahjat FR, Pine PR, Reitsma A, Cassafer G, Baluom M, Grillo S, Chang B, Zhao FF, Payan DG, Grossbard EB, Daikh DI: An orally bioavailable spleen tyrosine kinase inhibitor delays disease progression and prolongs survival in murine lupus. Arthritis Rheum. 2008, 58: 1433-1444. 10.1002/art.23428.
CAS
PubMed
Google Scholar
Deng GM, Liu L, Bahjat FR, Pine PR, Tsokos GC: Suppression of skin and kidney disease by inhibition of spleen tyrosine kinase in lupus-prone mice. Arthritis Rheum. 2010, 62: 2086-2092.
PubMed Central
CAS
PubMed
Google Scholar
Colonna L, Catalano G, Chew C, D'Agati V, Thomas JW, Wong FS, Schmitz J, Masuda ES, Reizis B, Tarakhovsky A, Clynes R: Therapeutic targeting of Syk in autoimmune diabetes. J Immunol. 2010, 185: 1532-1543. 10.4049/jimmunol.1000983.
PubMed Central
CAS
PubMed
Google Scholar
Barr PM, Wei C, Roger J, Schaefer-Cutillo J, Kelly JL, Rosenberg AF, Jung J, Sanz I, Friedberg JW: Syk inhibition with fostamatinib leads to transitional B lymphocyte depletion. Clin Immunol. 2012, 142: 237-242. 10.1016/j.clim.2011.12.012.
PubMed Central
CAS
PubMed
Google Scholar
Honigberg LA, Smith AM, Sirisawad M, Verner E, Loury D, Chang B, Li S, Pan Z, Thamm DH, Miller RA, Buggy JJ: The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy. Proc Natl Acad Sci USA. 2010, 107: 13075-13080. 10.1073/pnas.1004594107.
PubMed Central
CAS
PubMed
Google Scholar
Chang BY, Huang MM, Francesco M, Chen J, Sokolove J, Magadala P, Robinson WH, Buggy JJ: The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells. Arthritis Res Ther. 2011, 13: R115-10.1186/ar3400.
PubMed Central
CAS
PubMed
Google Scholar
Durand CA, Hartvigsen K, Fogelstrand L, Kim S, Iritani S, Vanhaesebroeck B, Witztum JL, Puri KD, Gold MR: Phosphoinositide 3-kinase p110 delta regulates natural antibody production, marginal zone and B-1 B cell function, and autoantibody responses. J Immunol. 2009, 183: 5673-5684. 10.4049/jimmunol.0900432.
CAS
PubMed
Google Scholar
Bartok B, Boyle DL, Liu Y, Ren P, Ball ST, Bugbee WD, Rommel C, Firestein GS: PI3 kinase delta is a key regulator of synoviocyte function in rheumatoid arthritis. Am J Pathol. 2012, 180: 1906-1916. 10.1016/j.ajpath.2012.01.030.
CAS
PubMed
Google Scholar
Dil N, Marshall AJ: Role of phosphoinositide 3-kinase p110 delta in TLR4-and TLR9-mediated B cell cytokine production and differentiation. Mol Immunol. 2009, 46: 1970-1978. 10.1016/j.molimm.2009.03.010.
CAS
PubMed
Google Scholar
Hennessy EJ, Parker AE, O'Neill LA: Targeting Toll-like receptors: emerging therapeutics?. Nat Rev Drug Discov. 2010, 9: 293-307. 10.1038/nrd3203.
CAS
PubMed
Google Scholar
Katz SJ, Russell AS: Re-evaluation of antimalarials in treating rheumatic diseases: re-appreciation and insights into new mechanisms of action. Curr Opin Rheumatol. 2011, 23: 278-281. 10.1097/BOR.0b013e32834456bf.
CAS
PubMed
Google Scholar
Lee SJ, Silverman E, Bargman JM: The role of antimalarial agents in the treatment of SLE and lupus nephritis. Nat Rev Nephrol. 2011, 7: 718-729. 10.1038/nrneph.2011.150.
CAS
PubMed
Google Scholar
Goldman FD, Gilman AL, Hollenback C, Kato RM, Premack BA, Rawlings DJ: Hydroxychloroquine inhibits calcium signals in T cells: a new mechanism to explain its immunomodulatory properties. Blood. 2000, 95: 3460-3466.
CAS
PubMed
Google Scholar
Sacre K, Criswell LA, McCune JM: Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Res Ther. 2012, 14: R155-10.1186/ar3895.
PubMed Central
CAS
PubMed
Google Scholar
Yu SL, Chan PK, Wong CK, Szeto CC, Ho SC, So K, Yu MM, Yim SF, Cheung TH, Wong MC, Cheung JL, Yeung AC, Li EK, Tam LS: Antagonist-mediated down-regulation of toll-like receptors increases the prevalence of human papillomavirus infection in systemic lupus erythematosus. Arthritis Res Ther. 2012, 14: R80-10.1186/ar3803.
PubMed Central
CAS
PubMed
Google Scholar
Clark EA, Ledbetter JA: How does B cell depletion therapy work, and how can it be improved?. Ann Rheum Dis. 2005, 64 (Suppl 4): iv77-iv80.
PubMed Central
CAS
PubMed
Google Scholar